Health
Study: Thymoquinone selectively kills prostate cancer cells at advanced stages – News-Medical.Net
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.
Reviewed by Emily Henderson, B.Sc.Oct 8 2020
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports that prostate cancer cells with a deletion of the SUCLA2 gene can be therapeutically targeted.
SUCLA2-deficient prostate cancers represent a significant fraction of those resistant to hormone therapy or metastatic, and a new therapeutic option for this …
-
Noosa News8 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News20 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News21 hours agoFarmgate Backpackers leads with integrity amid industry challenges
-
Noosa News14 hours agoGood Charlotte are Touring Australia and New Zealand in 2026